|
Krebs Biochemicals & Industries Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
148.03 Cr.
|
P/BV
|
-1.01
|
Book Value (Rs.)
|
-67.83
|
|
52 Week High/Low (Rs.)
|
114/64
|
FV/ML
|
10/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
27/09/2023
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 43.31 | 50.42 | 26.64 | 52.94 | 38.61 |
| Other Operating Revenues | 0.00 | 0.00 | 25.50 | 6.76 | 15.09 |
| Total Operating Revenues | 43.31 | 50.42 | 52.13 | 59.70 | 53.70 |
| | | | | | |
| Other Income | 0.71 | 0.45 | 0.62 | 1.16 | 0.62 |
| Total Revenue | 44.02 | 50.87 | 52.75 | 60.86 | 54.32 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 2.49 | 5.43 | 15.36 | 46.18 | 25.62 |
| Purchase Of Stock-In Trade | 0.04 | 0.09 | 4.44 | 0.00 | 0.00 |
| Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 33.06 | 26.28 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 3.03 | 1.07 | 5.87 | -5.54 | 0.32 |
| Employee Benefit Expenses | 16.60 | 16.47 | 15.84 | 15.30 | 15.83 |
| Finance Costs | 5.91 | 4.69 | 2.97 | 5.39 | 6.28 |
| Depreciation And Amortisation Expenses | 6.69 | 6.77 | 6.56 | 6.30 | 5.12 |
| Other Expenses | 36.19 | 36.08 | 26.39 | 4.70 | 3.22 |
| Total Expenses | 70.94 | 70.60 | 77.45 | 105.39 | 82.68 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | -26.92 | -19.73 | -24.69 | -44.53 | -28.36 |
| | | | | | |
| Profit/Loss Before Tax | -26.92 | -19.73 | -24.69 | -44.53 | -28.36 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Tax For Earlier Years | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Tax Expenses | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | -26.94 | -19.73 | -24.69 | -44.53 | -28.36 |
| | | | | | |
| Profit/Loss From Continuing Operations | -26.94 | -19.73 | -24.69 | -44.53 | -28.36 |
| | | | | | |
| Profit/Loss For The Period | -26.94 | -19.73 | -24.69 | -44.53 | -28.36 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | -12.49 | -9.16 | -11.30 | -20.81 | -14.53 |
| Diluted EPS (Rs.) | -12.49 | -9.16 | -11.30 | -20.81 | -14.53 |
